| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
group | 0.200 | None | 0.958 | 48 | 0 | 1990 | 2019 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
group | 0.100 | None | 1.000 | 36 | 0 | 1987 | 2013 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
group | 0.100 | None | 0.957 | 23 | 0 | 2007 | 2019 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1992 | 2019 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 1997 | 2019 | |||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 1991 | 2019 | |||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 2017 | 2019 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.100 | None | 0.923 | 13 | 0 | 1995 | 2016 | |||||||||
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene) | 0.566 | 0.654 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1997 | 2019 | |||||||||
|
H3 histone pseudogene 23 | 0.443 | 0.769 |
|
group | 0.080 | None | 0.875 | 8 | 0 | 1995 | 2016 | |||||||||
|
miR-17-92a-1 cluster host gene | 0.483 | 0.808 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2004 | 2018 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2009 | 2017 | |||||||||
|
Cbl proto-oncogene like 2 | 0.476 | 0.808 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2018 | |||||||||
|
uncharacterized LOC105379528 | 0.617 | 0.615 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1997 | 2011 | |||||||||
|
immunoglobulin heavy chain variable region | 0.617 | 0.615 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1997 | 2011 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1997 | 2003 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2011 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 1194 | 0.470 | 0.769 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2017 | |||||||||
|
H3 histone pseudogene 12 | 0.603 | 0.615 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1993 | 1996 | |||||||||
|
H3 histone pseudogene 9 | 0.505 | 0.731 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1995 | 2002 | |||||||||
|
H3 histone pseudogene 8 | 0.544 | 0.808 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2005 | |||||||||
|
endogenous retrovirus group W member 1, envelope | 0.505 | 0.692 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2010 | |||||||||
|
microRNA 150 | 0.455 | 0.808 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2014 | |||||||||
|
microRNA 17 | 0.459 | 0.846 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2018 | |||||||||
|
microRNA 18a | 0.520 | 0.846 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2018 |